Cargando…

Small Molecule Drugs in Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBDs), mainly represented by Crohn’s disease (CD) and Ulcerative Colitis (UC), are chronic disorders with an unclear pathogenesis. This incurable and iterative intestinal mucosal inflammation requires the life-long use of anti-inflammatory drugs to prevent flares or rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben Ghezala, Inès, Charkaoui, Maëva, Michiels, Christophe, Bardou, Marc, Luu, Maxime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308576/ https://www.ncbi.nlm.nih.gov/pubmed/34209234 http://dx.doi.org/10.3390/ph14070637

Ejemplares similares

Enteric Viruses and Inflammatory Bowel Disease
por: Tarris, Georges, et al.
Publicado: (2021)

Specific Norovirus Interaction with Lewis x and Lewis a on Human Intestinal Inflammatory Mucosa during Refractory Inflammatory Bowel Disease
por: Tarris, Georges, et al.
Publicado: (2021)

New biologics and small molecules in inflammatory bowel disease: an update
por: Sabino, João, et al.
Publicado: (2019)

Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs
por: Na, Soo-Young, et al.
Publicado: (2022)

Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases
por: Reinglas, Jason, et al.
Publicado: (2018)

Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies
por: Cheah, Eric, et al.
Publicado: (2023)

Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease
por: Xu, Yi-Han, et al.
Publicado: (2022)

Iranian Consensus Guideline for Pharmacotherapy with Biologics and Small Molecules Drugs in Adults with Inflammatory Bowel Diseases
por: Khoshnam-Rad, Niloofar, et al.
Publicado: (2023)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Genetic polymorphisms of inflammatory molecules in Tunisian inflammatory bowel diseases
por: Gorgi, Y, et al.
Publicado: (2010)

Efficacy of a Novel Prefilled, Single-Use, Needle-Free Device (Zeneo(®)) in Achieving Intramuscular Agent Delivery: An Observational Study
por: Bardou, Marc, et al.
Publicado: (2016)

Explore Small Molecule-induced Genome-wide Transcriptional Profiles for Novel Inflammatory Bowel Disease Drug
por: Cai, Xiaoshu, et al.
Publicado: (2016)

Worms and the Treatment of Inflammatory Bowel Disease: Are Molecules the Answer?
por: Ruyssers, Nathalie E., et al.
Publicado: (2008)

Mining the Microbiome and Microbiota-Derived Molecules in Inflammatory Bowel Disease
por: Bekkers, Matthijs, et al.
Publicado: (2021)

Small Bowel Endoscopy in Inflammatory Bowel Disease
por: Yamagami, Hirokazu, et al.
Publicado: (2013)

Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease
por: Balderramo, Domingo
Publicado: (2022)

miRNA Molecules—Late Breaking Treatment for Inflammatory Bowel Diseases?
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

Microbiota and Drug Response in Inflammatory Bowel Disease
por: Franzin, Martina, et al.
Publicado: (2021)

Drug Targeting of Inflammatory Bowel Diseases by Biomolecules
por: Antunes, Joana Costa, et al.
Publicado: (2021)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development
por: Rao, Praveen P. N., et al.
Publicado: (2010)

Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
por: Klein, Amir, et al.
Publicado: (2010)

Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory Bowel Disease
por: Bilal, Muhammad, et al.
Publicado: (2021)

Inflammatory bowel disease—the role of cross-sectional imaging techniques in the investigation of the small bowel
por: Athanasakos, Athanasios, et al.
Publicado: (2014)

Current and emerging drugs for the treatment of inflammatory bowel disease
por: Triantafillidis, John K, et al.
Publicado: (2011)

Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease
por: Zakerska-Banaszak, Oliwia, et al.
Publicado: (2022)

Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease
por: Alayo, Quazim A, et al.
Publicado: (2022)

Breaking the Therapeutic Ceiling: Dual Biologic or Small Molecule Therapy for Refractory Inflammatory Bowel Disease
por: Ahmed, Waseem
Publicado: (2022)

Fast-track drug approval in inflammatory bowel diseases
por: Katsanos, Konstantinos H., et al.
Publicado: (2016)

Inflammatory Bowel Disease Drugs: A Focus on Autophagy
por: Hooper, Kirsty M., et al.
Publicado: (2017)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Natural Product-Derived Drugs for the Treatment of Inflammatory Bowel Diseases
por: Joo, Young-Eun
Publicado: (2014)

Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics
por: Deyhim, Tina, et al.
Publicado: (2023)

The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease—A Systematic Literature Review
por: Wiersma, Thomas K., et al.
Publicado: (2022)

Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune‐mediated inflammatory diseases: A European retrospective observational study
por: Goessens, Laurent, et al.
Publicado: (2021)

The role of small-bowel endoscopy in inflammatory bowel disease: an updated review on the state-of-the-art in 2021
por: Skamnelos, Alexandros, et al.
Publicado: (2021)

Effectiveness of Dual Biologic or Small Molecule Therapy for Achieving Endoscopic Remission in Refractory Inflammatory Bowel Disease
por: Abdullah, Israa, et al.
Publicado: (2022)

Inflammatory bowel disease: clinical aspects and treatments
por: Fakhoury, Marc, et al.
Publicado: (2014)

New treatment options for inflammatory bowel diseases
por: Verstockt, Bram, et al.
Publicado: (2018)

The Bowel Microbiota and Inflammatory Bowel Diseases
por: Tannock, Gerald W.
Publicado: (2010)

Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids
por: Ben Ghezala, Inès, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5abibrclplbt7l1b3c75na7l7j